McDermott Will & Schulte has strong expertise across a broad range of equity capital markets transactions including IPOs, follow-on offerings and private placements. Chicago-based Eric Orsic co-leads the practice and is noted for his work on public equity, tender offers and going-private transactions. Washington DC-based Thomas Conaghan co-leads the department and advises both US and foreign public companies. The arrival of Craig Garvey from Kirkland & Ellis LLP in May 2025 brought additional depth in high-yield note offerings and issuer-side IPOs to the group. The team was further strengthened by the firm’s broader merger with Schulte Roth & Zabelin in August 2025.
Legal 500 Editorial commentary
Accolades
Client satisfaction: Lawyer & team quality
Client satisfaction: Billing & efficiency
Client satisfaction: Sector knowledge
Client satisfaction: NPS ®
Testimonials
Collated independently by Legal 500 research team.
- 'One of the key qualities that distinguishes the firm is their blend of legal rigour with commercial sense.'
Key clients
- Tether Investments, S.A. de C.V
- BofA Securities, Inc
- Inhibikase Therapeutics, Inc
- AirSculpt Technologies, Inc
- Spine BioPharma
- Applied DNA Sciences
- Esousa Holdings LLC
- Compeer Financial
- Constellation Brands, Inc
- RFA Management Company, LLC
Work highlights
Advised Tether Investments, S.A. de C.V on a $775 million strategic investment in Rumble, resulting in Tether acquiring 103,333,333 of newly issued shares Class A Common Stock.
Assisted Tether Investments, S.A. de C.V with a cross-border partial tender offer to acquire a controlling interest in Adecoagro S.A., valued at $615.5 million.
Advised Spine BioPharma through the issuance of $26 million of Series D preferred stock.
Practice head
Eric Orsic; Thomas Conaghan
Other key lawyers
Craig Garvey; Dan Woodard